Bausch Health Companies Aktie - BVF

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

3,921

Gebot

3,9015

Fragen

3,9395

Volumen

122

3,926 Tagesbereich 3,926

3,7235 52-Wochen-Bereich 9,36

Handelsende

3,986

Handelsbeginn

3,926

Letzte Trade

3.926

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

4.126

Finanzvolumen

VWAP

Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller

MOUNTAIN VIEW, Calif., Feb. 22 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced today that Mark K. Oki has been...

Former Executive Director of the World Bank and CEO of OMERS Nominated as Directors for Biovail Corporation's Board of Directors

* Biovail Shareholders Asked to Support Two Independent Directors That are Not Tied to Management or to Eugene Melnyk * TORONTO, May 11...

GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million

RESEARCH TRIANGLE PARK, N.C., May 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE:GSK) today announced that it has entered into an...

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC Investigation of...

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit HARTFORD, Nov. 21 /PRNewswire/ -- The...

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and Financial...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-0.1175	-2.90949610004	4.0385	4.2	3.8705	18392	4.10462833	DE
4	-0.8075	-17.0772972401	4.7285	4.83	3.8705	4178	4.14679602	DE
12	-3.301	-45.7075602326	7.222	7.222	3.7275	4126	4.4399411	DE
26	-3.668	-48.3331137172	7.589	8.179	3.7275	3029	5.46791758	DE
52	-2.051	-34.3436034829	5.972	9.36	3.7235	2259	5.64385351	DE
156	-3.863	-49.6274409044	7.784	9.893	3.7235	1733	6.24619442	DE
260	-3.863	-49.6274409044	7.784	9.893	3.7235	1733	6.24619442	DE

BVF - Frequently Asked Questions (FAQ)

What is the current Bausch Health Companies share price?

The current share price of Bausch Health Companies is 3,921 €

What is the 1 year trading range for Bausch Health Companies share price?

Bausch Health Companies has traded in the range of 3,7235 € to 9,36 € during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
CBOImunon Inc	1,00 € (171,74%)	71k
4APApollo Minerals Ltd	0,011 € (57,14%)	1,69k
85G1StGeorges EcoMining Corp	0,0515 € (51,47%)	8k
CNM1Carnegie Clean Energy Limited	0,0372 € (43,08%)	60,1k
N7ONLightbridge Corp	13,32 € (40,65%)	11,58k
E3O1Nexoptic Technology Corp	0,006 € (-29,41%)	130,36k
DN3Metaplanet Inc	6,04 € (-27,92%)	8,56M
1SSNextech3d Ai Corp	0,015 € (-27,88%)	40k
CNWCodon AG	0,0145 € (-27,50%)	243
VJFVital Metals Ltd	0,0011 € (-26,67%)	500k
DN3Metaplanet Inc	6,04 € (-27,92%)	8,56M
D7GNel ASA	0,2134 € (-1,02%)	4,3M
VSLDigital X Ltd	0,0358 € (-9,60%)	3,05M
34Q0Quantum eMotion Inc	0,574 € (17,38%)	2,89M
RQ0DWave Quantum Inc	16,48 € (-2,46%)	2,31M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Bausch Health Companies Inc (BVF)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

BVF Neueste Nachrichten

Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller

Former Executive Director of the World Bank and CEO of OMERS Nominated as Directors for Biovail Corporation's Board of Directors

GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and

/ C O R R E C T I O N -- Scott + Scott, LLC /

Scott + Scott, LLC Files Securities Lawsuit Against Biovail

Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Biovail Corporation and Others

Biovail Reports Third Quarter 2003 Financial Results - Correction

BVF - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Bausch Health Companies Inc (BVF) Börsenkurse

Bausch Health Companies Inc (BVF)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

BVF Neueste Nachrichten

Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller

Former Executive Director of the World Bank and CEO of OMERS Nominated as Directors for Biovail Corporation's Board of Directors

GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million

Schatz & Nobel, P.C. Provides Update to Biovail Investors who Purchased BVF From May 17, 2002 to October 30, 2003 Concerning SEC

Schatz & Nobel, P.C. Provides Update Concerning SEC Investigation of Biovail and Class Action Lawsuit

Scott + Scott, LLC Files Securities Action on Behalf of Biovail Shareholders; SEC Opens Inquiry Into Drugmaker's Accounting and

/ C O R R E C T I O N -- Scott + Scott, LLC /

Scott + Scott, LLC Files Securities Lawsuit Against Biovail

Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Biovail Corporation and Others

Biovail Reports Third Quarter 2003 Financial Results - Correction

BVF - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Anmelden

Werbung entfernen